Watch this on-demand webcast of a live CCO presentation on distinguishing tardive dyskinesia from drug-induced parkinsonism and why it is important to treat sooner rather than later.
The presentation will focus on tardive dyskinesia, clinical pearls to distinguish it from other drug-induced movement disorders, and how assessment of the impact of tardive dyskinesia can aid treatment decisions with first-line VMAT2 inhibitor therapy.
An expert provides insights on best practices for identification and management of Parkinson’s disease psychosis.
Listen as Marwan Sabbagh, MD, FAAN, and Marta San Luciano, MD, MS, FAAN, discuss clinical strategies for diagnosing and managing Parkinson’s disease psychosis.
Watch this on-demand webcast of a live CCO presentation on the diagnosis and management of Parkinson’s disease dementia.
The presentation will discuss the cardinal features of Parkinson’s disease dementia, how it differs from dementia with Lewy bodies and Parkinson’s disease, diagnostic strategies, and pharmacologic and nonpharmacologic strategies.
Seizure action plans are underused in the adult population, putting people with epilepsy at risk for suboptimal care in the event of a seizure. In this case example, Aatif Husain, MD, describes a woman with epilepsy and how he has used rescue therapies and a seizure action plan to help her live a safer life.
Listen as Aatif Husain, MD, and John Stern, MD, discuss the role of rescue therapies in the spectrum of epilepsy management.
Slides from the epilepsy presentation at the 2022 Movement Disorders+ Summit.
Watch this on-demand webcast of a live CCO presentation on epilepsy and the importance of incorporating rescue medications and seizure action plan into patient care.
Slides from the migraine presentation at the 2022 Movement Disorders+ Summit.
This presentation will discuss how to recognize the psychiatric symptoms associated with dementia, the on-label and off-label medications and strategies used in Alzheimer’s disease psychosis, and dementia-related psychosis, and new and emerging treatments for treating neuropsychiatric symptoms in Alzheimer’s disease dementia.
This presentation will educate healthcare providers on the historical treatment of myasthenia gravis, how the newer agents change the treatment paradigm, and demonstrate how to treat various subtypes of myasthenia gravis through patient case examples.
The presentation will focus on patients with Parkinson’s disease, motor fluctuation, and dyskinesia and the use of adjunctive therapies to levodopa to improve their OFF time and improve their good time during the day.
Slides from the hyperkinetic movement disorders presentation at the 2022 Movement Disorders+ Summit.
The presentation will focus on the indications and appropriateness for surgical therapies (deep brain stimulation, carbidopa/levodopa intestinal gel therapy, and high frequency MR-guided focused ultrasound) in Parkinson’s disease.
Slides from the essential tremor presentation at the 2022 Movement Disorders+ Summit.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.